RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5193
Malaria parasiteP. berghei
Genotype
TaggedGene model (rodent): PBANKA_1003000; Gene model (P.falciparum): PF3D7_0405300; Gene product: liver specific protein 2, putative (LISP2)
Name tag: Cre recombinase
Phenotype Liver stage;
Last modified: 21 July 2022, 12:37
  *RMgm-5193
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene tagging
Reference (PubMed-PMID number) Reference 1 (PMID number) : 35858541
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/Researcherda Silva CM, Kurup P
Name Group/DepartmentDepartment of Cellular Biology
Name InstituteUniversity of Georgia
CityAthens, GA
CountryUSA
Name of the mutant parasite
RMgm numberRMgm-5193
Principal namePb-Cre
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot tested
Gametocyte/GameteNot tested
Fertilization and ookineteNot tested
OocystNot tested
SporozoiteNot tested
Liver stageEvidence presented that LISP2 tagged with Cre recombinase is exported into hepatocytes and that the Cre-recombinase is active in infected hepatocytes
Additional remarks phenotype

Mutant/mutation
The mutant expresses LISP2 C-terminal tagged as follows: Pb-Cre parasites were generated by fusing Cre recombinase with an SV40 nuclear localization signal (NLS) and HA tag on the C-terminus of Lisp2 by CRISPR-mediated insertion of these coding sequences in the endogenous pblisp2 genomic locus.

CRISPR-mediated insertion/tagging was performed using the CRISPR-RGR technology described for mutant RMgm-4633.

Protein (function)
Evidence has been presented that LISP2 plays a role in development of maturing liver schizonts. LISP2 is specifically expressed in (late) liver stages. Evidence has been presented for export of LISP2 into the cytoplasm of the hepatocyte. The protein has been named LISP2 and sequestrin.

Phenotype
Evidence presented that LISP2 tagged with Cre recombinase is exported into hepatocytes and that the Cre-recombinase is active in infected hepatocytes (see below).

Additional information
To demonstrate the extent to which Pb-Cre can ablate target DNA sequences in host hepatocytes, we infected primary hepatocytes derived from Ai14 mice with Pb-Cre. Ai14 mice possess a floxed STOP cassette preventing the transcription of a CAG promoter-driven red fluorescent protein variant, tdTomato. Upon excision of the STOP cassette, tdTomato expression is ‘turned on’ in Ai14 cells. Ai14 hepatocytes infected with Pb-Cre showed robust tdTomato expression, indicating that Pb-Cre can be reliably used to ablate floxed target DNA sequences in Plasmodium-infected cells.

Other mutants


  Tagged: Mutant parasite with a tagged gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1003000
Gene Model P. falciparum ortholog PF3D7_0405300
Gene productliver specific protein 2, putative
Gene product: Alternative nameLISP2
Details of the genetic modification
Name of the tagCre recombinase
Details of taggingC-terminal
Additional remarks: taggingThe mutant expresses LISP2 C-terminal tagged as follows: Pb-Cre parasites were generated by fusing Cre recombinase with an SV40 nuclear localization signal (NLS) and HA tag on the C-terminus of Lisp2 by CRISPR-mediated insertion of these coding sequences in the endogenous pblisp2 genomic locus.
CRISPR-mediated insertion/tagging was performed using the CRISPR-RGR technology described for mutant RMgm-4633.
Commercial source of tag-antibodies
Type of plasmid/constructCRISPR/Cas9 construct: integration through double strand break repair
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationPb-Cre parasites were generated by fusing Cre recombinase with an SV40 nuclear localization signal (NLS) and HA tag on the C-terminus of Lisp2 by CRISPR-mediated insertion of these coding sequences in the endogenous pblisp2 genomic locus.
CRISPR-mediated insertion was performed using the CRISPR-RGR technology described for mutant RMgm-4633.
Generation of Pblisp2 CRISPR-RGR plasmid A CRISPR-RGR plasmid for the insertion of Cre recombinase, SV40 NLS, and a 1xHA tag was created using pSL1394 as a base plasmid (Addgene # 129522). A homology-directed repair (HDR) template was constructed that consists of: 1) a 5’ homology arm (5’ HA) comprising 411bp of the 3’ end of the pblisp2 coding sequence, 2) coding sequence for a 2x(GGS) flexible linker, Cre, SV40 NLS, a single HA tag, and a stop codon, and 3) a 3’ homology arm (3’ HA) comprising 306bp of the sequences immediately downstream of pblisp2. Additionally, a Ribozyme-Guide[1]Ribozyme sequence was synthesized as previously described(Walker and Lindner, 2019; RMgm-4633) that expressed two sgRNAs with perfect homology to the targeted region of pblisp2. Distinct and unique promoter and 3’UTR sequences were used for each transcriptional cassette to avoid recombination and removal of Plasmodium sequences in the plasmid.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6